Skip to main content

Dr. Scott Gottlieb, a physician and conservative health policy expert, is expected to lead the U.S. Food and Drug Administration, sources told Reuters.

Gottlieb may be appointed by the White House as early as today.

Gottlieb, 44, is a former FDA deputy commissioner who frequently argued for a loosening of provisions needed for approval of new medical products.

He is a resident fellow at the conservative American Enterprise Institute, a think tank, and partner at New Enterprise Associates, a large venture capital fund.

Scroll to Continue

TheStreet Recommends